Please try another search
Name | Title | Since | Until |
---|---|---|---|
Linden Thomson | - | 2024 | Now |
Rudi Van den Eynde | Senior Portfolio Manager, Equities | 2018 | Now |
Biography | Due to European regulatory GDPR guidelines, Candriam cannot provide personal details as education or professional background to databases outside Europe. Information available on request only. | ||
Servaas Michielssens | - | 2018 | 2022 |
Biography | Servaas Michielssens has been a Senior Analyst at Candriam since 2016, and became co-manager of the Biotechnology and Oncology strategy since November 2018. He began his career as a PhD student at the University of Leuven Belgium in 2007, where he obtained his PhD in science in 2011. In 2012 he became a postdoctoral scholar at the Max Planck Institute for Biophysical Chemistry in Germany. Servaas holds a master degree in chemistry from the University of Leuven, Belgium and a PhD in science from the same university. Servaas is also a CFA charterholder. |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review